1. Introduction
===============

Marine organisms, which have developed unique metabolic and physiological capabilities to ensure survival in extreme ocean habitats, offer the potential to produce new bioactive constituents that would not be observed from terrestrial organisms \[[@B1-marinedrugs-10-01433]\]. Soft corals belonging to the genus *Sarcophyton* (Alcyoniidae) have been well recognized as a rich source of terpenoids \[[@B1-marinedrugs-10-01433]\]. These constituents, mainly macrocyclic cembrane-type diterpenoids and their derivatives, represent important chemical defense substances for the animals against their natural predators \[[@B2-marinedrugs-10-01433]\]. Cembranoids have been previously reported to exhibit a range of biological activities including antitumor \[[@B3-marinedrugs-10-01433],[@B4-marinedrugs-10-01433],[@B5-marinedrugs-10-01433],[@B6-marinedrugs-10-01433],[@B7-marinedrugs-10-01433],[@B8-marinedrugs-10-01433],[@B9-marinedrugs-10-01433]\], ichthyotoxic \[[@B10-marinedrugs-10-01433]\], anti-inflammatory \[[@B11-marinedrugs-10-01433]\], neuroprotective \[[@B12-marinedrugs-10-01433]\], antibacterial \[[@B13-marinedrugs-10-01433]\], antiangiogenic \[[@B14-marinedrugs-10-01433]\], antimetastatic \[[@B14-marinedrugs-10-01433]\], anti-osteoporotic \[[@B15-marinedrugs-10-01433]\], and cytotoxic \[[@B16-marinedrugs-10-01433],[@B17-marinedrugs-10-01433],[@B18-marinedrugs-10-01433]\] properties. Among them, sarcophine (**4**) was reported to have antimetastatic activity \[[@B14-marinedrugs-10-01433]\].

Twelve cembranoids were previously reported from the soft coral *Sarcophyton ehrenbergi* \[[@B1-marinedrugs-10-01433],[@B19-marinedrugs-10-01433]\]. The samples for our previous studies on the secondary metabolites of the soft coral *S. ehrenbergi* were all collected at Dongsha Atoll \[[@B19-marinedrugs-10-01433],[@B20-marinedrugs-10-01433]\]. Chemical investigation of the Taiwanese soft coral *S. ehrenbergi* ([Figure 1](#marinedrugs-10-01433-f001){ref-type="fig"}) collected at San-Hsian-Tai (Taitong County) has afforded three new cembranoids, designated as (+)-12-ethoxycarbonyl-11*Z*-sarcophine (**1**), ehrenbergol A and B (**2** and **3**) ([Figure 2](#marinedrugs-10-01433-f002){ref-type="fig"}). Herein, we describe the purification, structure elucidation, cytotoxicity and antiviral evaluation of these metabolites in detail.

![Soft coral *Sarcophyton ehrenbergi*.](marinedrugs-10-01433-g001){#marinedrugs-10-01433-f001}

![Structures of compounds **1**--**4**.](marinedrugs-10-01433-g002){#marinedrugs-10-01433-f002}

2. Results and Discussion
=========================

The HRESIMS of **1** exhibited a pseudomolecular ion peak at *m/z* 397.1993 \[M + Na\]^+^, consistent with the molecular formula of C~22~H~30~O~5~, requiring eight degrees of unsaturation. IR absorption at 1754 cm^−1^ and NMR signals ([Table 1](#marinedrugs-10-01433-t001){ref-type="table"}) at *δ*~C~ 174.4 (qC, C-16), 160.7 (qC, C-1), 124.2 (qC, C-15), 78.2 (CH, C-2), and 8.6 (CH~3~, C-17); *δ*~H~ 5.57 (1H, dd, *J* = 10.0, 2.0 Hz, H-2) and 1.90 (3H, s, H~3~-17) were indicative of an α,β-unsaturated γ-lactone functionality by comparison with those of similar metabolites, such as the corresponding data of sarcophine (**4**) \[[@B6-marinedrugs-10-01433]\]. The IR absorption bands at 1705 cm^−1^ and NMR signals at *δ*~H~ 6.80 (1H, dd *J* = 10.4, 4.8 Hz, H-11), 4.23 (2H, m, H~2~-21), 1.32 (1H, t, *J* = 7.2 Hz, H-22); *δ*~C~ 166.9 (qC, C-20), 131.1 (qC, C-12), and 142.0 (CH, C-11) indicated the presence of α,β-unsaturated ethyl ester \[[@B20-marinedrugs-10-01433]\]. In addition, a trisubstituted epoxide was present in **1** from its ^1^H NMR signals at *δ*~H~ 2.56 (1H, br d, *J* = 6.4 Hz, H-7) and ^13^C NMR signals at *δ*~C~ 61.3 (qC, C-8) and 62.4 (CH, C-7). Moreover, the ^13^C NMR signals at *δ*~C~ 121.1 (CH, C-3), and 144.5 (qC, C-4) were assigned a trisubstituted double bond. The above functionalities account for seven of the eight degrees of unsaturation, suggesting a tricyclic structure in **1**.
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###### 

NMR data for compound **1**.

  Position   *δ*~H~ *^a^* (*J* in Hz)   *δ*~C~ *^b^*, Type   HMBC           COSY         NOESY
  ---------- -------------------------- -------------------- -------------- ------------ ----------
  1                                     160.7, C                                         
  2          5.57, dd (10, 2.0)         78.2, CH                            3, 17        18
  3          5.08, d (10.4)             121.1, CH            5, 18          2, 18        5a
  4                                     144.5, C                                         
  5a         2.39, m                    37.7, CH2            3, 4, 6, 18    5b, 6a       3, 5b, 7
  5b         2.41, m                    3, 4, 6, 18          5a, 6a         5a,18        
  6a         1.92, m                    22.9, CH~2~                         6b, 5a, 5b   6b
  6b         1.72, m                                         6a, 7          6a,18, 19    
  7          2.56, br d (6.4)           62.4, CH             6              6b           9a, 10a
  8                                     61.3, C                                          
  9a         0.97, m                    38.2, CH~2~          10             9b           9b, 11
  9b         2.22, m                    11                   9a, 10a, 10b   7, 9a, 19    
  10a        2.11, m                    25.9, CH~2~          12             9a, 10b      7, 10b
  10b        2.19, m                                         9a, 10a, 11    10a          
  11         6.80, dd (10.4, 4.8)       142.0, CH            10, 13, 20     10a          9b
  12                                    131.1, C                                         
  13         2.36, m                    25.2, CH~2~          12, 20         14b          
  14a        2.50, m                    27.0, CH~2~          1, 2, 15       14b          14b
  14b        2.11, m                                         13a, 14a       14a          
  15                                    124.2, C                                         
  16                                    174.4, C                                         
  17         1.90, s                    8.6, CH~3~           1, 15, 16      2            
  18         1.87, s                    15.3, CH~3~          3, 4, 5        3            2, 5b
  19         1.30, s                    16.8, CH~3~          7, 8, 9                     6b, 9b
  20                                    166.9. C                                         
  21         4.23, m                    60.8, CH~2~          20             22           22
  22         1.33, t (7.2)              14.3, CH~3~          21             21           21

*^a^* Spectra were measured in CDCl~3~ (400 MHz); *^b^* Spectra were measured in CDCl~3~ (100 MHz).

By interpretation of ^1^H-^1^H COSY correlations, it was possible to establish three partial structures of consecutive proton systems extending from H-2 to H-3, from H~2~-5 to H-7 through H~2~-6, from H~2~-9 to H-11 through H~2~-10, and from H~2~-13 to H~2~-14. Subsequently, the connectivities of these partial structures were further established by the HMBC correlations ([Figure 3](#marinedrugs-10-01433-f003){ref-type="fig"}). HMBC correlations observed from H~3~-19 to C-7, C-8, and C-9 indicated the position of the epoxide at C-7 and C-8. Moreover, the HMBC correlations from H-11 to C-9, C-10, C-12, C-13, and C-20 and from H~2~-21 to C-20 as well as COSY correlation between H~2~-21 and H~3~-22, led the assignment of the ethoxycarbonyl at C-12. The locations of the double bond at C-3/C-4 was clarified by analysis of the HMBC correlations from Me-18 to C-3, C-4, and C-5. The molecular framework of **1** was further established by other HMBC correlations between H~2~-14 to C-1, C-2, C-15 and H~3~-17 to C-1, C-15, C-16.

![COSY and HMBC correlations of compounds **1**--**3**.](marinedrugs-10-01433-g003){#marinedrugs-10-01433-f003}

The relative configuration of **1** assigned by a NOESY spectrum was compatible with that suggested by computer modeling, in which the close contacts of atoms calculated in space were consistent with the NOESY correlations ([Figure 4](#marinedrugs-10-01433-f004){ref-type="fig"}). The presence of a NOESY cross peak between the vinylic H-11 and H~2~-9 (*δ*~H~ 2.22) suggested the *E* geometry for the C-11/C-12 double bond, which was also identified by the chemical shift of H-11 at *δ*~H~ 6.80 \[[@B19-marinedrugs-10-01433],[@B21-marinedrugs-10-01433]\]. The geometry of the trisubstituted olefin at C-3/C-4 was assigned as *E* based on the higher field chemical shift of the olefinic methyl signal for C-18 (*δ*~C~ 15.3). Furthermore, the crucial NOE correlations between H-2/Me-18, Me-18/H-6b (*δ*~H~ 1.72), Me-19/H-6b, Me-19/H-9b (*δ*~H~ 2.22), H-7/H-6a (*δ*~H~ 1.92), and H-7/H-9b, H-7/H-5a (*δ*~H~ 2.39), and H-3/H-5a demonstrated the 2*S*\*, 7*S*\*, and 8*S*\* configurations as depicted in [Figure 4](#marinedrugs-10-01433-f004){ref-type="fig"}. A careful analysis of all the NMR spectroscopic data (COSY, HSQC, HMBC, and NOESY) confirmed that **1** is actually the 12-ethoxycarbonyl derivative of (+)-11*Z*-sarcophine \[[@B19-marinedrugs-10-01433],[@B22-marinedrugs-10-01433]\]. All of the NMR spectroscopic data of **1** were consistent with the structure shown as (+)-12-ethoxycarbonyl-11*Z*-sarcophine.

Ehrenbergol A (**2**) was assigned a molecular formula of C~21~H~32~O~4~, according to its HRESIMS and NMR spectroscopic data ([Table 2](#marinedrugs-10-01433-t002){ref-type="table"}). The IR absorptions of **2** at 1715 cm^−1^ revealed the presence of an α,β-unsaturated methyl ester functionality, which was confirmed by its NMR spectroscopic data \[*δ*~H~ 6.89 (1H, dd, *J* = 10.4, 6.8 Hz, H-11) and 3.42 (3H, s, H~3~-21); *δ*~C~ 167.6 (qC, C-20), 133.9 (qC, C-12), 141.1 (CH, C-11), and 51.2 (CH~3~, COOMe)\]. The NMR spectroscopic data also indicated that **2** possesses a trisubstituted epoxide \[*δ*~H~ 2.67 (1H, dd, *J* = 10.8, 2.8 Hz, H-7); *δ*~C~ 60.6 (qC, C-8) and 62.1 (CH, C-7)\], and two trisubstituted olefins \[*δ*~H~ 6.53 (1H, d, *J* = 11.0 Hz, H-2) and 6.08 (1H, d, *J* = 11.0 Hz, H-3); *δ*~C~ 147.1 (qC, C-1), 118.4 (CH, C-2), 123.8 (CH, C-3), and 135.8 (qC, C-4)\]. The above functionalities account for five of the six degrees of unsaturation, suggesting that **2** must consist of a 14-membered ring diterpenoid skeleton.

![NOESY correlations of compound **1**.](marinedrugs-10-01433-g004){#marinedrugs-10-01433-f004}
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###### 

NMR data for compound **2**.

  Position   *δ*~H~ *^a^* (*J* in Hz)   *δ*~C~ *^b^*, Type   HMBC           COSY           NOESY
  ---------- -------------------------- -------------------- -------------- -------------- -------------
  1                                     147.1, C                                           
  2          6.53, d (11.0)             118.4, CH            4, 14, 15      3              16, 17, 18
  3          6.08, d (11.0)             123.8, CH            5, 18          2, 18          5a, 7, 13a
  4                                     135.8, C                                           
  5a         2.12, m                    37.8, CH~2~          3              5b, 18         3, 5b
  5b         1.97, m                    3                    5a, 6b, 18     5a, 6b, 18     
  6a         1.94, m                    25.5, CH~2~          7              6b, 7          6b
  6b         1.17, m                                         5b, 6a, 7      5b, 6a,19      
  7          2.67, dd (10.8, 2.8)       62.1, CH                            6a, 6b         3, 9a
  8                                     60.6, C                                            
  9a         0.85, td (12.4, 4.0)       39.7, CH~2~          8, 19          9b, 10a, 10b   9b, 7
  9b         1.95, m                    8, 10, 19            9a, 10a, 10b   9a, 19         
  10a        2.16, m                    26.7, CH~2~                         9, 10b, 11     10b
  10b        1.75,m                     9, 11, 12            9, 10a, 11     10a, 19        
  11         6.89, dd (10.4, 6.8)       141.1, CH            20             10a, 10b       9
  12                                    133.9, C                                           
  13a        2.26,m                     28.4, CH~2~                                        3, 13b, 14b
  13b        2.38, m                    11, 12, 20                          13a            
  14a        2.52, m                    28.6, CH~2~          12                            14b, 17
  14b        2.24, m                    12                                  14a            
  15                                    73.6, C                                            
  16         1.33, s                    29.5, CH~3~          1, 15, 17                     2
  17         1.44, s                    29.3, CH~3~          1, 16, 17                     2
  18         1.58, s                    15.6, CH~3~          3, 4, 5        3, 5a, 5b      2, 5b
  19         1.04, s                    15.6, CH~3~          7, 8, 9                       6b, 9b, 10b
  20                                    167.6, C                                           
  21         3.42, s                    51.2, CH~3~          20                            

*^a^* Spectra were measured in CDCl~3~ (400 MHz); *^b^* Spectra were measured in CDCl~3~ (100 MHz).

The structure of **2** was established through COSY and HMBC experiments ([Figure 3](#marinedrugs-10-01433-f003){ref-type="fig"}). Crucial HMBC correlations from Me-18 to C-3, C-4, and C-5, from Me-19 to C-7, C-8, and C-9, from H-11 to C-10, C-12, C-13, and C-20, and from Me-16/Me-17 to C-15 and C-1 confirmed the connectivity among these partial structures ([Figure 3](#marinedrugs-10-01433-f003){ref-type="fig"}). The position of the methoxycarbonyl at C-12 was established by the HMBC correlations from H-11 and H-13 to C-20 and from H~3~-21 to C-20. A COSY experiment established a correlation between the two vinylic protons at *δ*~H~ 6.53 (H-2) and 6.08 (H-3). These results allowed the assignment of the planar structure of **2** as shown.

The configurations of all double bonds were determined from a NOESY experiment on **2**. The crucial NOE correlations ([Figure 5](#marinedrugs-10-01433-f005){ref-type="fig"}) between H-2 (*δ*~H~ 6.53)/Me-16 (*δ*~H~ 1.33), H-2/Me-18 (*δ*~H~ 1.44), and H-3 (*δ*~H~ 6.08)/H-5a (*δ*~H~ 2.12) indicated that the geometries of the conjugated diene at C-1/C-2 and C-3/C-4 were both *E*. The large coupling constant (*J*~2,3~ = 11.0 Hz) further suggested the *s*-*trans* geometry of the conjugated double bonds \[[@B20-marinedrugs-10-01433],[@B21-marinedrugs-10-01433]\]. The presence of a NOESY cross peak between the vinylic H-11 and H~2~-9 made it possible to identify the configuration of the olefin at C-11/C-12 as the *E* geometry, which was also confirmed by the chemical shift of H-11 at *δ*~H~ 6.89 \[[@B20-marinedrugs-10-01433]\]. Moreover, the crucial NOESY correlations between Me-19/H-6b (*δ*~H~ 1.16), Me-19/H-9b (*δ*~H~ 1.94), H-7/H-6a (*δ*~H~ 1.97), H-7/H-9b (*δ*~H~ 1.95), and H-7/H-5a (*δ*~H~ 2.12) demonstrated the configurations of C-7 and C-8 as 7*S*∗ and 8*S*\*, respectively. On the basis of the aforementioned observations and other detailed NOESY correlations ([Figure 4](#marinedrugs-10-01433-f004){ref-type="fig"}), the structure of ehrenbergol A (**2**) was established.

![NOESY correlations of compound **2**.](marinedrugs-10-01433-g005){#marinedrugs-10-01433-f005}

The positive HRESIMS spectrum of ehrenbergol B (**3**) exhibited a pseudo molecular ion peak at *m/z* 387.2509 \[M + Na\]^+^, consistent with the molecular formula of C~22~H~36~O~4~, implying five degrees of unsaturation. The presence of two oxygenated methine \[*δ*~H~ 3.40 (d, 1H, *J* = 7.6 Hz) and *δ*~C~ 85.1 (C-7); *δ*~H~ 3.32 (dd, 1H, *J* = 11.2, 2.0 Hz) and *δ*~C~ 80.1 (C-11)\] implied that an ether linkage is present between C-7 and C-11, which was confirmed by the HMBC correlations from H-7 to C-11, and from H-11 to C-7. The NMR spectroscopic data ([Table 3](#marinedrugs-10-01433-t003){ref-type="table"}) indicated that **3** possesses a conjugated diene \[*δ*~H~ 5.89 (1H, d, *J* = 5.0 Hz) and 5.99 (1H, d, *J* = 5.0 Hz); *δ*~C~ 150.2 (qC, C-1), 119.6 (CH, C-2), 122.3 (CH, C-3), and 137.1 (qC, C-4)\] and an acetoxy \[*δ*~C~ 169.2 (qC), 21.9 (CH~3~) and *δ*~H~ 1.67 (3H, s)\];. The above functionalities account for three of the five degrees of unsaturation, implying that **3** is a cembranoid characterized by the presence of an ether linkage between C-7 and C-11.
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###### 

NMR data for compound **3**.

  Position   *δ*~H~ *^a^* (*J* in Hz)   *δ*~C~ *^b^*, Type   HMBC                 COSY            NOESY
  ---------- -------------------------- -------------------- -------------------- --------------- ---------------
  1                                     150.2, qC                                                 
  2          5.89, br d (5.0)           119.6, CH            4, 14, 15            3               3, 15, 16, 18
  3          5.99, br d (5.0)           122.3, CH            1, 5, 18             2, 18           2, 5a
  4                                     137.1, qC                                                 
  5          2.16, m                    39.6, CH~2~          3, 4, 6, 7           6a, 6b          3, 7, 6b, 18
  6a         1.42, m                    26.5, CH~2~          8                    5a, 5b, 6b      5b, 19
  6b         1.69, m                    4, 5, 7              5a, 5b, 6a                           
  7          3.40, d (7.6)              85.1, CH             5, 6, 8, 9, 11, 19                   5a, 9a
  8                                     80.7, qC                                                  
  9a         1.73, m                    35.4, CH~2~                               9b, 10a, 10b    7, 9b, 11
  9b         2.83, dt (12.4, 4.0)       19                   9a, 10a, 10b         9a, 10b, 19     
  10a        1.56, m                    23.0, CH~2~                               10b             10b, 11
  10b        1.39, m                                         10a                  10b, 20         
  11         3.32, dd (11.2, 2.0)       80.1, CH             7, 12, 20            10a, 10b        9a, 10a, 14a
  12                                    73.0, qC                                                  
  13a        1.46, m                    41.0, CH~2~          20                   13b, 14a        
  13b        1.80, m                    12, 20               13a                  17, 20          
  14a        2.22, m                    24.0, CH~2~          1, 2                 13a, 13b, 14b   3, 11
  14b        1.77, m                    13                   14a                                  
  15         2.28, m                    35.2, CH             16, 17               16, 17          2, 16, 17
  16         1.08, d (7.2)              22.0, CH~3~          1, 15, 17            15              2, 15
  17         1.10, d (6.4)              22.6, CH~3~          1, 15, 16            15              2, 13b, 15
  18         1.64, s                    17.2, CH~3~          3, 4, 5              3               2, 5b
  19         1.50, s                    17.1, CH~3~          7, 8, 9                              6b, 9b
  20         1.01, s                    23.8, CH~3~          11, 12, 13                           10b, 13b
  OAc        1.67, s                    169.2, qC                                                 
                                        21.9, CH~3~                                               

*^a^* Spectra were measured in C~6~D~6~ (400 MHz); *^b^* Spectra were measured in C~6~D~6~ (100 MHz).

The final assembly of **3** was determined by the information from COSY and HMBC experiments. The ^1^H-^13^C long-range correlations as determined from the HMBC spectrum allowed the connectivity of the structural fragments around each methyl group to be deduced ([Figure 3](#marinedrugs-10-01433-f003){ref-type="fig"}). The crucial NOESY correlations ([Figure 6](#marinedrugs-10-01433-f006){ref-type="fig"}) proved that the geometries of the conjugated diene at C-1/C-2 and C-3/C-4 were both *E*. The coupling constant (*J*~2,3~ = 5.0 Hz) further suggested the *s*-*cis* geometry of the above functionality \[[@B20-marinedrugs-10-01433],[@B21-marinedrugs-10-01433]\]. The key NOESY correlations between H-3/H-14a (*δ*~H~ 2.22), H-14a/H-11, H-11/H-7, H-11/H-9a (*δ*~H~ 1.73), H-11/H-10a (*δ*~H~ 1.56), H-7/H-9b, H-7/H-3, H-7/H-5 (*δ*~H~ 2.16), Me-19/H-9b (*δ*~H~ 2.83), Me-20/H-10b (*δ*~H~ 1.39), and Me-20/H-13b (*δ*~H~ 1.80) suggested that H-7, and H-11 are on the same face (β), whereas Me-19 and Me-20 are oriented toward the other face (α), as shown in a computer generated 3D drawing. The above findings indicated the 7*R*\*, 8*S*\*, 11*R*\*, and 12*S*\* configurations as depicted in [Figure 6](#marinedrugs-10-01433-f006){ref-type="fig"}. Therefore, the structure of **3** was elucidated as (7*R*\*,8*S*\*,11*R*\*,12*S*\*,1*Z*,3*E*)-8,12-dihydroxy-7,11-epoxycembra-1(2),3-diene 8-acetate.

![NOESY correlations of compound **3**.](marinedrugs-10-01433-g006){#marinedrugs-10-01433-f006}

The cytotoxicities of metabolites **1**--**3** against P-388 (mouse lymphocytic leukemia), HT-29 (human colon adenocarcinoma) tumor cells, and human embryonic lung (HEL) cells are shown in [Table 4](#marinedrugs-10-01433-t004){ref-type="table"}. Metabolites **1**--**3** were also examined for antiviral activity against human cytomegalovirus (HCMV) using a human embryonic lung (HEL) and displayed antiviral activity against human cytomegalovirus, with IC~50s~ of 60, 46, and 5.0 μg/mL, respectively.
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###### 

Cytotoxicit and anti-HCMV activity of **1**--**3**.

  Compounds   ED~50~ (μg/mL)                       
  ----------- ---------------- ------ ----- ------ -----
  1           20.8             \>50   5.8   \>50   60
  2           \>50             \>50   7.4   \>50   46
  3           10.2             \>50   4.7   \>50   5.0

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotations were determined with a JASCO P1020 digital polarimeter. UV and IR spectra were obtained on JASCO V-650 and JASCO FT/IR-4100 spectrophotometers, respectively. NMR spectra were recorded on a Varian MR 400 NMR spectrometer at 400 MHz for ^1^H and 100 MHz for ^13^C. ^1^H NMR chemical shifts are expressed in *δ* (ppm) referring to the solvent peak *δ*~H~ 7.27 for CHCl~3~ or *δ*~H~ 7.15 for C~6~D~6~, and coupling constants are expressed in Hz. ^13^C NMR chemical shifts are expressed in *δ* (ppm) referring to the solvent peak *δ*~C~ 77.0 for CDCl~3~ or *δ*~C~ 128.0 for C~6~D~6~. MS were recorded by a Bruker APEX II mass spectrometer. Silica gel 60 (Merck, Germany, 230--400 mesh) and LiChroprep RP-18 (Merck, 40--63 μm) were used for column chromatography. Precoated silica gel plates (Merck, Kieselgel 60 F~254~, 0.25 mm) and precoated RP-18 F~254s~ plates (Merck) were used for thin-layer chromatography (TLC) analysis. High-performance liquid chromatography (HPLC) was carried out using a Hitachi L-7100 pump equipped with a Hitachi L-7400 UV detector at 220 nm together with a semi-preparative reversed-phased column (Merck, Hibar LiChrospher RP-18e, 5 μm, 250 × 25 mm).

3.2. Biological Material
------------------------

The soft coral *S. ehrenbergi* was collected by SCUBA at San-Hsian-Tai, Taitong County, Taiwan, in July 2008 at a depth of 8 m and stored in a freezer until extraction. The voucher specimen (SST-13) was identified by Professor Chang-Feng Dai, National Taiwan University and deposited at the Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Taiwan.

3.3. Extraction and Isolation
-----------------------------

A specimen of soft coral *S. ehrenbergi* (4.0 kg) was minced and extracted with acetone (4 × 3 L) at room temperature. The combined acetone extracts were then partitioned between H~2~O and EtOAc. The resulting EtOAc extract (46.9 g) was subjected to gravity silica gel 60 column chromatography (Si 60 CC) using *n*-hexane and *n*-hexane/EtOAc of increasing polarity, to give 20 fractions. Fraction 15 (2.26 g), eluted with *n*-hexane/EtOAc (1:1), was further subjected to Si 60 CC (*n*-hexane/EtOAc, 7:1) to give 8 subfractions. A subfraction 15-4 (250 mg), was purified by RP-18 HPLC (MeOH/H~2~O, 75:25) to afford **2** (2.0 mg, 0.0005%).The fraction 14 (3.56 g), eluted with *n*-hexane/EtOAc (2:1), was further subjected to Si 60 CC (*n*-hexane/EtOAc, 8:1) to give 5 subfractions. A subfraction 14-2 (299 mg), was separated by a RP-18 flash column (MeOH/H~2~O, 60:40 to 100% MeOH) to give 6 fractions. The subfraction 14-2-6, eluted with MeOH/H~2~O (90:10), was purified by RP-18 HPLC (MeOH/H~2~O, 85:15) to afford **3** (2.4 mg, 0.0006%). A subfraction 14-3 (248 mg), was separated by a RP-18 flash column (MeOH/H~2~O, 50:50 to 100% MeOH) to give 7 fractions. The subfraction 14-3-3, eluted with MeOH/H~2~O (70:30), was purified by RP-18 HPLC (MeOH/H~2~O, 65:35) to afford **1** (3.2 mg, 0.0008%).

(+)-12-Ethoxycarbonyl-11*Z*-sarcophine (**1**): White amorphous powder; ![](marinedrugs-10-01433-i001.jpg) +77 (*c* 0.2, CHCl~3~); UV (MeOH) λ~max~ (log ε) 228 (3.72) nm; IR (neat) ν~max~ 3481, 2933, 1754, 1705, 1455, 1387, 1242, 1096, 991, 760 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) and ^13^C NMR (CDCl~3~, 100 MHz) data in [Table 1](#marinedrugs-10-01433-t001){ref-type="table"}; HRESIMS *m/z* 397.1993 \[M + Na\]^+^ (calcd for C~22~H~30~O~5~Na, 397.1991).

Ehrenbergol A (**2**): White amorphous powder; ![](marinedrugs-10-01433-i001.jpg) −184 (*c* 0.1, CHCl~3~); UV (MeOH) λ~max~ (log ε) 221 (3.72), 242 (3.32) nm; IR (neat) ν~max~ 3447, 2961, 2925, 2851, 1715, 1458, 1260, 1101, 1026, 799, 759 cm^−1^; ^1^H NMR (C~6~D~6~, 400 MHz) and ^13^C NMR (C~6~D~6~, 100 MHz) data in [Table 1](#marinedrugs-10-01433-t001){ref-type="table"}; HRESIMS *m/z* 371.2195 \[M + Na\]^+^ (calcd for C~21~H~32~O~4~Na, 371.2198).

Ehrenbergol B (**3**): White amorphous powder; ![](marinedrugs-10-01433-i001.jpg) −84.0 (*c* 0.1, CHCl~3~); IR (neat) ν~max~ 3461, 2959, 1737, 1634, 1456, 1378, 1259, 1089, 1026, 801 cm^−1^; ^1^H NMR (C~6~D~6~, 400 MHz) and ^13^C NMR (C~6~D~6~, 100 MHz) data in [Table 2](#marinedrugs-10-01433-t002){ref-type="table"}; HRESIMS *m/z* 387.2509 \[M + Na\]^+^ (calcd for C~22~H~36~O~4~Na, 387.2511).

3.4. Cytotoxicity Assay
-----------------------

Cytotoxicity was determined on P-388 (mouse lymphocytic leukemia), HT-29 (human colon adenocarcinoma), and A-549 (human lung epithelial carcinoma) tumor cells using a modification of the MTT colorimetric method according to a previously described procedure \[[@B23-marinedrugs-10-01433],[@B24-marinedrugs-10-01433],[@B25-marinedrugs-10-01433]\]. The provision of the P-388 cell line was supported by J.M. Pezzuto, formerly of the Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago. HT-29 and A-549 cell lines were purchased from the American Type Culture Collection. To measure the cytotoxic activities of tested compounds, five concentrations with three replications were performed on each cell line. Mithramycin was used as a positive control.

3.5. Anti-HCMV Assay
--------------------

To determine the effects of natural products upon HCMV cytopathic effect (CPE), confluent human embryonic lung (HEL) cells grown in 24-well plates were incubated for 1 h in the presence or absence of various concentrations of tested natural products with three replications. Ganciclovir was used as a positive control. Then, cells were infected with HCMV at an input of 1000 pfu (plaque forming units) per well of a 24-well dish. Antiviral activity was expressed as IC~50~ (50% inhibitory concentration), or compound concentration required to reduce virus induced CPE by 50% after 7 days as compared with the untreated control. To monitor the cell growth upon treating with natural products, an MTT-colorimetric assay was employed \[[@B26-marinedrugs-10-01433],[@B27-marinedrugs-10-01433]\].

4. Conclusion
=============

The first investigation of soft coral *S. ehrenbergi* collected at San-Hsian-Tai (Taitong County, Taiwan) has led to the isolation of three new cembranoids, (+)-12-ethoxycarbonyl-11*Z*-sarcophine (**1**) as well as ehrenbergol A and B (**2** and **3**). Metabolites **1**--**3** were not cytotoxic towards P-388 (mouse lymphocytic leukemia), HT-29 (human colon adenocarcinoma) tumor cells, and human embryonic lung (HEL) cells. However, metabolites **1**--**3** displayed antiviral activity towards human cytomegalovirus, with IC~50~s of 60, 46, and 5.0 μg/mL, respectively. Ehrenbergol B is the first cembranoid from Taiwanese soft corals to show potent anti-HCMV activity.
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